A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study

• Main Authors: Matthew K. Hoffman (Author), Shivaprasad S. Goudar (Author), Bhalachandra S. Kodkany (Author), Norman Goco (Author), Marion Koso-Thomas (Author), Menachem Miodovnik (Author), Elizabeth M. McClure (Author), Dennis D. Wallace (Author), Jennifer J. Hemingway-Foday (Author), Antoinette Tshefu (Author), Adrien Lokangaka (Author), Carl L. Bose (Author), Elwyn Chomba (Author), Musaku Mwenechanya (Author), Waldemar A. Carlo (Author), Ana Garces (Author), Nancy F. Krebs (Author), K. Michael Hambidge (Author), Sarah Saleem (Author), Robert L. Goldenberg (Author), Archana Patel (Author), Patricia L. Hibberd (Author), Fabian Esamai (Author), Edward A. Liechty (Author), Robert Silver (Author), Richard J. Derman (Author)
• Format: Book
• Published: BMC, 2017-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Preterm birth (PTB) remains the leading cause of neonatal mortality and long term disability throughout the world. Though complex in its origins, a growing body of evidence suggests that first trimester administration of low dose aspirin (LDA) may substantially reduce the rate of...